Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease. Parkinson's Disease Research Group of the United Kingdom. [electronic resource]
Producer: 19960227Description: 1602-7 p. digitalISSN:- 0959-8138
- Antiparkinson Agents -- adverse effects
- Benserazide -- administration & dosage
- Bromocriptine -- administration & dosage
- Cause of Death
- Disability Evaluation
- Drug Administration Schedule
- Drug Therapy, Combination
- Follow-Up Studies
- Humans
- Levodopa -- administration & dosage
- Monoamine Oxidase Inhibitors -- administration & dosage
- Parkinson Disease -- drug therapy
- Proportional Hazards Models
- Prospective Studies
- Selegiline -- administration & dosage
- Time Factors
- Treatment Failure
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.